Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

Collegium Pharmaceutical Ownership Summary


Collegium Pharmaceutical is owned by 52.94% institutional investors, 0.94% insiders, and 46.13% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.19% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.95% of its assets in Collegium Pharmaceutical shares.

COLL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCollegium Pharmaceutical52.94%0.94%46.13%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.67%13.90%65.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.13M16.19%$169.78M
Vanguard group2.26M7.15%$104.46M
Janus henderson group1.83M5.76%$60.36M
Invesco1.59M5.02%$52.64M
Fuller & thaler asset management1.50M4.73%$49.59M
Renaissance1.47M4.63%$48.59M
State street1.42M4.49%$47.11M
Eventide asset management1.42M4.49%$47.08M
Massachusetts financial services co /ma/1.37M4.31%$45.17M
Principal financial group1.30M4.08%$42.83M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ballast asset management, lp113.22K1.67%$3.74M
Tejara capital77.00K0.84%$2.55M
Third avenue management155.14K0.83%$5.13M
Eventide asset management1.42M0.78%$47.08M
Hussman strategic advisors105.00K0.75%$3.47M
Emerald mutual fund advisers trust306.07K0.49%$10.12M
Watershed asset management13.58K0.47%$449.02K
Summerhaven investment management22.76K0.46%$752.54K
Rubric capital management lp1.28M0.45%$42.32M
Emerald advisers402.75K0.42%$13.32M

Top Buyers

HolderShares% AssetsChange
Invesco1.59M0.01%416.87K
Janus henderson group1.83M0.03%377.07K
Qube research621.93K0.02%353.69K
Millennium management360.83K0.01%290.54K
Marshall wace, llp748.81K0.02%256.45K

Top Sellers

HolderShares% AssetsChange
Eventide asset management1.42M0.78%-451.96K
J. goldman & co lp---243.45K
Pacer advisors---240.89K
Quantedge capital pte---237.75K
Emerald advisers402.75K0.42%-226.59K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust219.36K0.00%219.36K$7.25M
Norges bank112.50K0.00%112.50K$5.21M
Hussman strategic advisors105.00K0.75%105.00K$3.47M
Peregrine capital management96.31K0.12%96.31K$3.18M
Tejara capital77.00K0.84%77.00K$2.55M

Sold Out

HolderChange
Clearstead advisors-1.00
Stephens consulting-1.00
Lindbrook capital-2.00
Larson financial group-2.00
Concord wealth partners-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026158-43.17%16,783,792-54.78%520.38%85-37.04%45-58.72%
Dec 31, 2025189-22.54%28,523,231-22.90%900.67%83-36.15%77-10.47%
Sep 30, 20252327.91%36,812,0797.39%1151.00%12314.95%846.33%
Jun 30, 2025219-10.61%35,601,778-3.13%1110.84%106-2.75%83-15.31%
Mar 31, 20252-99.17%369,275-99.01%10.01%1-99.07%1-98.91%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.93M5.95%495.00
FullerThaler Beh Small-Cap Equity SMA1.43M4.51%-
FullerThaler Behavioral Small-Cap Equity1.43M4.51%-
FullerThaler Behavioral Sm-Cp Eq R61.43M4.51%-
Eventide Gilead N1.34M4.23%-
Vanguard US Total Market Shares ETF993.93K3.09%-
Janus Henderson Hrzn Glb SC E2 USD981.71K3.03%-1.75K
Vanguard Total Stock Mkt Idx Inv948.66K2.93%-
iShares Russell 2000 ETF737.17K2.27%6.20K
MFS New Discovery I585.15K1.80%46.21K

Recent Insider Transactions


DateNameRoleActivityValue
May 18, 2026Freund John Gordon-Sell$681.00
May 15, 2026Freund John Gordon-Sell$142.55K
May 13, 2026Lurker Nancy-Sell$161.86K
May 11, 2026BOHLIN GAREN G-Sell$323.49K
Mar 18, 2026Dieter David EVP & General CounselSell$488.10K

Insider Transactions Trends


DateBuySell
2026 Q2-4
2026 Q1-3
2025 Q4-6
2025 Q3-6
2025 Q2-1

COLL Ownership FAQ


Who Owns Collegium Pharmaceutical?

Collegium Pharmaceutical shareholders are primarily institutional investors at 52.94%, followed by 0.94% insiders and 46.12% retail investors. The average institutional ownership in Collegium Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Collegium Pharmaceutical exceeds.

Who owns the most shares of Collegium Pharmaceutical?

Collegium Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (5.13M shares, 16.19%), Vanguard group (2.26M shares, 7.15%), and Janus henderson group (1.83M shares, 5.76%). Together, they hold 29.10% of Collegium Pharmaceutical’s total shares outstanding.

Does Blackrock own Collegium Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Collegium Pharmaceutical.

Who is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Ballast asset management, lp is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 1.67% of its assets in 113.22K Collegium Pharmaceutical shares, valued at 3.74M$.

Who is the top mutual fund holder of Collegium Pharmaceutical shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Collegium Pharmaceutical shares, with 5.95% of its total shares outstanding invested in 1.93M Collegium Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools